Pretreatment with Cry1Ac protoxin modulates the immune response, and increases the survival of Plasmodium-infected CBA/Ca mice.
Legorreta-Herrera
Martha
M
Laboratorio de Inmunología Molecular, Facultad de Estudios Superiores Zaragoza, Universidad Nacional Autónoma de México, Iztapalapa 09230, Mexico. marthal@servidor.unam.mx
Meza
Rodrigo Oviedo
RO
Moreno-Fierros
Leticia
L
D000818:Animals; D000083722:Bacillus thuringiensis Toxins; D001426:Bacterial Proteins / Q000008:administration & dosage*; D016207:Cytokines / Q000276:immunology*; D004731:Endotoxins / Q000008:administration & dosage*; D005260:Female; D006460:Hemolysin Proteins / Q000008:administration & dosage*; D007113:Immunity, Innate / Q000187:drug effects* / Q000276:immunology*; D008288:Malaria / Q000188:drug therapy* / Q000276:immunology*; D008297:Male; D051379:Mice; D008808:Mice, Inbred CBA; D011292:Premedication / Q000379:methods*; D015996:Survival Rate; D016896:Treatment Outcome
D000083722:Bacillus thuringiensis Toxins; D001426:Bacterial Proteins; D016207:Cytokines; D004731:Endotoxins; D006460:Hemolysin Proteins; C030956:insecticidal crystal protein, Bacillus Thuringiensis